RETRACTED: β-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates β-adrenoceptor switching from G s to G i
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Phosphorylation of the β 2 adrenoreceptor (β 2 AR) by cAMP-activated protein kinase A (PKA) switches its predominant coupling from stimulatory guanine nucleotide regulatory protein (G s ) to inhibitory guanine nucleotide regulatory protein (G i ). β-Arrestins recruit the cAMP-degrading PDE4 phosphodiesterases to the β 2 AR, thus controlling PKA activity at the membrane. Here we investigate a role for PDE4 recruitment in regulating G protein switching by the β 2 AR. In human embryonic kidney 293 cells overexpressing a recombinant β 2 AR, stimulation with isoprenaline recruits β-arrestins 1 and 2 as well as both PDE4D3 and PDE4D5 to the receptor and stimulates receptor phosphorylation by PKA. The PKA phosphorylation status of the β 2 AR is enhanced markedly when cells are treated with the selective PDE4-inhibitor rolipram or when they are transfected with a catalytically inactive PDE4D mutant (PDE4D5-D556A) that competitively inhibits isoprenaline-stimulated recruitment of native PDE4 to the β 2 AR. Rolipram and PDE4D5-D556A also enhance β 2 AR-mediated activation of extracellular signal-regulated kinases ERK1/2. This is consistent with a switch in coupling of the receptor from G s to G i , because the ERK1/2 activation is sensitive to both inhibitors of PKA (H89) and G i (pertussis toxin). In cardiac myocytes, the β 2 AR also switches from G s to G i coupling. Treating primary cardiac myocytes with isoprenaline induces recruitment of PDE4D3 and PDE4D5 to membranes and activates ERK1/2. Rolipram robustly enhances this activation in a manner sensitive to both pertussis toxin and H89. Adenovirus-mediated expression of PDE4D5-D556A also potentiates ERK1/2 activation. Thus, receptor-stimulated β-arrestin-mediated recruitment of PDE4 plays a central role in the regulation of G protein switching by the β 2 AR in a physiological system, the cardiac myocyte.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Miggin, S. M., & Kinsella, B. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203353200 · Cited by 51
RetractedBradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A
Daaka, Y., Luttrell, L. M., & Lefkowitz, R. J. (1997) · Nature · doi:10.1038/36362 · Cited by 1,270
Self-citationTHE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
Krupnick, J. G., & Benovic, J. L. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.289 · Cited by 1,103
Seven-transmembrane-spanning receptors and heart function
Rockman, H. A., Koch, W. J., & Lefkowitz, R. J. (2002) · Nature · doi:10.1038/415206a · Cited by 938
Self-citationCyclic nucleotide research — still expanding after half a century
Beavo, J. A., & Brunton, L. L. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm911 · Cited by 903
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041604898 · Cited by 831
Self-citationHOUSLAY, M. D., & ADAMS, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 763
Self-citationPhosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
AKAPs: from structure to function
Colledge, M., & Scott, J. D. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01558-5 · Cited by 611
Desensitization of G-protein-coupled Receptors
Xiao, Z., Yao, Y., Long, Y., & Devreotes, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1440 · Cited by 521
Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D., et al. (2002) · Science · doi:10.1126/science.1074683 · Cited by 506
Self-citationThe Molecular Biology of Cyclic Nucleotide Phosphodiesterases
(1999) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60718-7 · Cited by 435
Grønborg, M., Kristiansen, T. Z., Stensballe, A., Andersen, J. S., Ohara, O., Mann, M., Jensen, O. N., & Pandey, A. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200010-mcp200 · Cited by 385
Microtubules in the Cytoplasm of an Amoeba
HOLBERTON, D. (1969) · Nature · doi:10.1038/222680a0 · Cited by 340
Atomic Structure of PDE4: Insights into Phosphodiesterase Mechanism and Specificity
Xu, R. X., Hassell, A. M., Vanderwall, D., Lambert, M. H., Holmes, W. D., Luther, M. A., Rocque, W. J., Milburn, M. V., Zhao, Y., Ke, H., et al. (2000) · Science · doi:10.1126/science.288.5472.1822 · Cited by 335
Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking
Miller, W. E., & Lefkowitz, R. J. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00190-3 · Cited by 322
Self-citationHouslay, M. D., Sullivan, M., & Bolger, G. B. (1998) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60128-3 · Cited by 290
Self-citationPKA Phosphorylation of Src Mediates cAMP's Inhibition of Cell Growth via Rap1
Schmitt, J. M., & Stork, P. J. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00432-4 · Cited by 251
PDE4 cAMP-specific phosphodiesterases
Houslay, M. D. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)69049-4 · Cited by 239
Self-citationMacKenzie, S. J., Baillie, G. S., McPhee, I., Bolger, G. B., & Houslay, M. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.22.16609 · Cited by 238
Self-citationFraser, I. D. C., Cong, M., Kim, J., Rollins, E. N., Daaka, Y., Lefkowitz, R. J., & Scott, J. D. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00419-x · Cited by 229
Self-citationHouslay, M. D., & Kolch, W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23096-0 · Cited by 202
Self-citationZamah, A. M., Delahunty, M., Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202753200 · Cited by 195
Self-citationDesensitization of G protein-coupled receptors.
Freedman, N. J., & Lefkowitz, R. J. (1996) · PubMed · Cited by 190
Self-citationLefkowitz, R. J., Pierce, K. L., & Luttrell, L. M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.971 · Cited by 180
Self-citationBaillie, G. S., MacKenzie, S. J., McPhee, I., & Houslay, M. D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703636 · Cited by 170
Self-citationBoth Gs and Gi Proteins Are Critically Involved in Isoproterenol-induced Cardiomyocyte Hypertrophy
Zou, Y., Komuro, I., Yamazaki, T., Kudoh, S., Uozumi, H., Kadowaki, T., & Yazaki, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9760 · Cited by 153
Phosphodiesterase 4 Inhibitors and the Treatment of Asthma
Giembycz, M. A. (2000) · Drugs · doi:10.2165/00003495-200059020-00004 · Cited by 151
Lawler, O. A., Miggin, S. M., & Kinsella, B. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104434200 · Cited by 147
Phosphorylation of Inositol 1,4,5-Trisphosphate Receptors in Parotid Acinar Cells
Bruce, J. I. E., Shuttleworth, T. J., Giovannucci, D. R., & Yule, D. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106609200 · Cited by 143
MacKenzie, S. J., & Houslay, M. D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470571 · Cited by 139
Self-citationZhang, H., & O’Donnell, J. M. (2000) · Psychopharmacology · doi:10.1007/s002130000414 · Cited by 136
Fan, G.-F., Shumay, E., Wang, H.-Y., & Malbon, C. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011199200 · Cited by 101
Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD)
Barnette, M. S. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8735-9_5 · Cited by 98
McLean, A. J., & Milligan, G. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703506 · Cited by 77
Baillie, G. S., MacKenzie, S. J., & Houslay, M. D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12520-5 · Cited by 71
Self-citationClerk, A., Kemp, T. J., Harrison, J. G., Mullen, A. J., Barton, P. J. R., & Sugden, P. H. (2002) · Biochemical Journal · doi:10.1042/bj20021083 · Cited by 62
Role of Arrestins in G-Protein-Coupled Receptor Endocytosis
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60780-2 · Cited by 50
Miggin, S. M., & Kinsella, B. T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.w118.004804 · Cited by 38
Cited by
Conti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
Lugnier, C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.003 · Cited by 870
Overview of PDEs and Their Regulation
Omori, K., & Kotera, J. (2007) · Circulation Research · doi:10.1161/01.res.0000256354.95791.f1 · Cited by 796
Advances in targeting cyclic nucleotide phosphodiesterases
Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 776
Localized Effects of cAMP Mediated by Distinct Routes of Protein Kinase A
TASKÉN, K., & AANDAHL, E. M. (2004) · Physiological Reviews · doi:10.1152/physrev.00021.2003 · Cited by 775
Metadata
- Authors
- Baillie, G. S., Sood, A., McPhee, I., Gall, I., Perry, S. J., Lefkowitz, R. J., & Houslay, M. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-01-27
- Volume
- 100
- Issue
- 3
- Pages
- 940-945
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2109771867
- Cited by
- 360
- References
- 42
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.